MRK Stock: Unusual Options Activity Flashes Bullish Signal as Merck Surges 2.41%
By TrendSpider Editor
Merck & Company is drawing attention in the options market today, with three unusual contracts totaling $2,076,491.50 in premium standing out against a backdrop of strong price action. Shares are trading at $118.22, up 2.41% on the session, putting the stock well above its 52-week low of $73.31
MRK Stock: Unusual Options Activity Flashes Bullish Signal as Merck Surges 2.41%
Merck & Company is drawing attention in the options market today, with three unusual contracts totaling $2,076,491.50 in premium standing out against a backdrop of strong price action. Shares are trading at $118.22, up 2.41% on the session, putting the stock well above its 52-week low of $73.31 and approaching its 52-week high of $125.14. The options flow, dominated by a sizable in-the-money call, suggests traders are positioning for continued upside as MRK grinds toward the top of its annual range.
Key Drivers of the MRK Stock Move
- Main Catalyst: Three unusual options contracts were flagged today carrying a combined premium of $2,076,491.50. The largest was a call at the $110 strike expiring today, April 17, 2026, with a size of 2,590 contracts and open interest utilization of 72%, currently in the money. Two put contracts at the $115 strike expiring June 17, 2027 also appeared, with sizes of 55 and 54 contracts respectively, both trading out of the money at elevated open interest ratios of 289% and 284%.
- Bull Case: The dominant contract is a deep in-the-money call expiring today, representing the vast majority of the $2,076,491.50 in total premium. With MRK trading at $118.22, the $110 call is $8.22 in the money, and the 72% open interest reading indicates meaningful new positioning. Combined with a 2.41% price gain on the day, this flow aligns with a bullish directional bet being pressed into the close.
- Bear Case: The two longer-dated put contracts at the $115 strike expiring June 17, 2027 are noteworthy despite their smaller size. Open interest ratios of 289% and 284% signal that volume is running well above existing open interest, meaning fresh bearish exposure is being added. With MRK sitting above $115, these out-of-the-money puts suggest at least some traders are hedging against or speculating on a pullback below current levels over the next 14 months.
Merck is approaching its 52-week high of $125.14, meaning the stock has roughly 5.8% of runway before testing that ceiling at current prices. The concentration of today's call activity at the $110 strike expiring today points more to a closing or rolling of existing positions than outright new bullish conviction, which traders should keep in mind when interpreting the headline premium figure. The longer-dated put positioning at $115 deserves monitoring heading into the coming weeks, particularly if any macro or company-specific headwinds emerge. With MRK having already made a substantial recovery from its 52-week low of $73.31, the risk-reward profile near the top of its range warrants careful attention from both momentum and contrarian perspectives.
MRK Unusual Options Activity
- Contract 1: Call | Strike: $110 | Expiry: April 17, 2026 | Volume: 2,590 | Open Interest Utilization: 72% | Status: In the Money
- Contract 2: Put | Strike: $115 | Expiry: June 17, 2027 | Volume: 55 | Open Interest Utilization: 289% | Status: Out of the Money
- Contract 3: Put | Strike: $115 | Expiry: June 17, 2027 | Volume: 54 | Open Interest Utilization: 284% | Status: Out of the Money
Total unusual contracts flagged today: 3. Total premium across all three contracts: $2,076,491.50. The call contract at $110 expiring today accounts for the overwhelming share of premium at $1,936,025, while the two put contracts contributed $71,076.50 and $69,390 respectively. The net directional lean of today's unusual flow is bullish by premium weight, though the out-of-the-money put activity expiring in June 2027 introduces a longer-term cautionary thread worth tracking.
MRK Seasonality
Mid-April historically coincides with first-quarter earnings season for large-cap pharmaceutical names, a period that can bring heightened volatility and options positioning as institutions adjust exposure around anticipated results. The presence of both short-dated calls and long-dated puts on the same day suggests traders may be managing near-term event risk while simultaneously building out longer-horizon hedges.
MRK Relative Performance
MRK's 2.41% gain today places it among the stronger movers in the large-cap pharmaceutical space on a session basis. Trading at $118.22, the stock sits substantially above its 52-week low of $73.31, representing a recovery of more than 61% from that trough, while remaining approximately 5.5% below the 52-week high of $125.14. The proximity to the annual high suggests MRK is outperforming on a trailing basis relative to where it spent much of the past year.